Electron crystallography can work with very small crystals because electrons interact strongly with matter. That interaction produces measurable diffraction information even when the ordered sample is smaller than the crystals typically required for X-ray crystallography. The practical consequence is access to structural targets that may be difficult to prepare in sufficiently large crystals for conventional X-ray analysis.
In two-dimensional protein arrays, electron microscope images provide projection views of regularly arranged molecules rather than relying only on a diffraction pattern. Combining these views computationally helps reconstruct molecular architecture, making the approach particularly informative for membrane proteins and other macromolecular assemblies whose organization is biologically important.
Computational reconstruction is central because individual diffraction patterns or microscope images do not directly provide a complete three-dimensional atomic model. Researchers combine the recorded information to infer molecular arrangement and compare structural states. This process can reveal conformational changes, meaning shifts in molecular shape or organization that may accompany biological activity.
Structural differences can connect a molecule’s architecture with its function. Reconstructed structures may be examined for features associated with ligand binding or for changes between conformational states. These observations help researchers investigate biological mechanisms and can provide structural evidence relevant to disease studies and drug-development efforts.
A typical workflow begins with a biological sample that forms a crystal or a regularly ordered array. An electron microscope then records either electron diffraction data or images of the ordered material. Computational analysis combines those measurements or projection views to reconstruct the three-dimensional arrangement, producing structural information that can be interpreted in a biological context.
The method is especially valuable when a target can be studied as a small crystal or as a two-dimensional protein array. Relevant examples include membrane-protein architecture and macromolecular complexes, as well as samples that adopt multiple conformational states. The resulting structures can clarify how molecular organization relates to biological function.
Electron crystallography supports disease and drug-development research by revealing structural features connected with ligand binding, molecular function, and conformational change. These observations can help relate a macromolecule’s three-dimensional organization to biological mechanisms. In turn, the structural information provides a basis for investigating disease-relevant changes and evaluating how molecular architecture may guide drug research.